Trial
NCT00094666
Elderly Primary Insomnia Polysomnographic Study (0928-002)(TERMINATED)
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
H. Lundbeck A/S
Collaborators
—
Condition
Primary Insomnia
Intervention
MK0928, gaboxadol / Duration of Treatment - 6 weeks
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-01-14